January 10, 2019
Rose
“If we don’t do this as an industry, I think there will be other alternatives that will be more onerous for us,” Johnson & Johnson CEO Alex Gorsky said at the J.P. Morgan Healthcare Conference in California. Drug pricing was just one of the many topics that were being hotly discussed at the annual event that draws the movers-and-shakers in the industry.
from Kaiser Health News http://bit.ly/2ADwbi3
January 10, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Leapfrog Issues Semi-Annual Hospital Safety Ratings Report- Viewpoints: Finally, Some Governors See Medicaid Work Requirements As Punitive; When Is It Ok For A Doctor To Refuse To Treat A Patient?
- HSAs Can Be A Powerful Savings Tool–But You Have To Know How To Utilize Them Right
- State Highlights: 911 Operators Cited As Lynchpins in NYC Medical Fraud Ring Affecting Thousands; Oregon’s ERs Reporting Striking Rise In Number Of Child Sexual Abuse Cases
- Kiosks Offer Unmanned Telehealth Clinics With Basic Pharmacy Meds, But Will Patients Actually Use Them When They’re Sick And On The Go?
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment